Envu India Backs National Conclave on Urban Vector Control, Charts Path to Eliminate Dengue-Malaria in Cities

IMT News Desk
IMT News Desk
· 2 min read
Envu India supports ISMOCD-AMC conclave. Experts tackle dengue, malaria in cities via AI surveillance, WHO IVM, larvicides.

A two-day national conclave on urban pest management and vector-borne disease control concluded in Ahmedabad, uniting public health leaders to tackle rising dengue, malaria, and chikungunya cases in India’s cities.

Organised by the Indian Society for Malaria and Other Communicable Diseases (ISMOCD) with Ahmedabad Municipal Corporation (AMC) and supported by Envu India, the event drew experts from national programmes, Armed Forces Medical College (AFMC), academia, and international scientists. Key sessions covered AI-assisted surveillance, the WHO’s Integrated Vector Management, the Urban Malaria Scheme, and innovations in insecticides.

Envu India highlighted global experience from Malaysia’s iDEM programme, advocating WHO-prequalified water-based larvicides over diesel-heavy fogging, which CSE research shows consumes 4.5 lakh litres in Delhi alone per season.

“Vector-borne diseases, caused by viruses, bacteria, and parasites, account for over 17% of infectious diseases globally, all transmitted through vectors. India has made remarkable progress in controlling these diseases. Malaria deaths have declined from eight lakh annually at independence to just 83 in 2023. Kala-azar cases dropped from 9,241 in 2014 to 449 in 2024, nearing elimination, while over 100 districts have eliminated lymphatic filariasis as a public health problem. Dengue mortality has also reduced significantly. These achievements reflect India’s sustained commitment to disease control,” said Padma Shri Prof. Dr. Aditya Prasad Dash, former Vice Chancellor, Central University of Tamil Nadu, and former WHO Adviser.

He added, “India aims to eliminate malaria, lymphatic filariasis, and kala-azar by 2030. Achieving this, especially in urban areas, requires stronger collaboration among scientific institutions, government bodies, and municipal agencies. Growing partnerships between academia, industry, and research organisations in innovation, technology transfer, and policy are key to this effort. Strengthening such collaborations will be critical for achieving India’s Sustainable Development Goals.”

Dr. Bhavin Solanki, AMC Medical Officer, praised Envu’s inputs: “Conclaves like this strengthen collaborations for measurable results.”

M. Arun Kumar, Envu India MD, added: “India’s cities are ready for advanced mosquito control. Envu is committed long-term alongside public health institutions.”

Envu welcomes partnerships with urban bodies for larvicidal transitions to interrupt breeding cycles effectively.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk